These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31481936

  • 1. Action of Dicumarol on Glucosamine-1-Phosphate Acetyltransferase of GlmU and Mycobacterium tuberculosis.
    Han X, Chen C, Yan Q, Jia L, Taj A, Ma Y.
    Front Microbiol; 2019; 10():1799. PubMed ID: 31481936
    [Abstract] [Full Text] [Related]

  • 2. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C, Mehra R, Sharma R, Chib R, Wazir P, Nargotra A, Khan IA.
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [Abstract] [Full Text] [Related]

  • 3. GlmU inhibitor from the roots of Euphorbia ebracteolata as an anti-tuberculosis agent.
    Han X, Chen C, Wang H, Kang J, Yan Q, Ma Y, Wang W, Wu S, Wang C, Ma X.
    RSC Adv; 2022 Jun 14; 12(28):18266-18273. PubMed ID: 35800323
    [Abstract] [Full Text] [Related]

  • 4. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
    Zhang W, Jones VC, Scherman MS, Mahapatra S, Crick D, Bhamidi S, Xin Y, McNeil MR, Ma Y.
    Int J Biochem Cell Biol; 2008 Jun 14; 40(11):2560-71. PubMed ID: 18573680
    [Abstract] [Full Text] [Related]

  • 5. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on Mycobacterium tuberculosis May Be Affected Due to Its Methylation by Methyltransferase Rv0560c.
    Chen C, Han X, Yan Q, Wang C, Jia L, Taj A, Zhao L, Ma Y.
    Front Cell Infect Microbiol; 2019 Jun 14; 9():251. PubMed ID: 31380295
    [Abstract] [Full Text] [Related]

  • 6. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
    Sharma R, Lambu MR, Jamwal U, Rani C, Chib R, Wazir P, Mukherjee D, Chaubey A, Khan IA.
    J Biomol Screen; 2016 Apr 14; 21(4):342-53. PubMed ID: 26762501
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R, Rani C, Mehra R, Nargotra A, Chib R, Rajput VS, Kumar S, Singh S, Sharma PR, Khan IA.
    Appl Microbiol Biotechnol; 2016 Apr 14; 100(7):3071-85. PubMed ID: 26563552
    [Abstract] [Full Text] [Related]

  • 8. Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU.
    Zhou Y, Xin Y, Sha S, Ma Y.
    Arch Microbiol; 2011 Oct 14; 193(10):751-7. PubMed ID: 21594607
    [Abstract] [Full Text] [Related]

  • 9. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK, Soni V, Vithani N, Jhingan GD, Bais VS, Nandicoori VK, Prakash B.
    J Biol Chem; 2012 Nov 16; 287(47):39524-37. PubMed ID: 22969087
    [Abstract] [Full Text] [Related]

  • 10. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
    Parikh A, Verma SK, Khan S, Prakash B, Nandicoori VK.
    J Mol Biol; 2009 Feb 20; 386(2):451-64. PubMed ID: 19121323
    [Abstract] [Full Text] [Related]

  • 11. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Tran AT, Wen D, West NP, Baker EN, Britton WJ, Payne RJ.
    Org Biomol Chem; 2013 Dec 14; 11(46):8113-26. PubMed ID: 24158720
    [Abstract] [Full Text] [Related]

  • 12. The Mechanism of Acetyl Transfer Catalyzed by Mycobacterium tuberculosis GlmU.
    Craggs PD, Mouilleron S, Rejzek M, de Chiara C, Young RJ, Field RA, Argyrou A, de Carvalho LPS.
    Biochemistry; 2018 Jun 19; 57(24):3387-3401. PubMed ID: 29684272
    [Abstract] [Full Text] [Related]

  • 13. Kinetic modelling of GlmU reactions - prioritization of reaction for therapeutic application.
    Singh VK, Das K, Seshadri K.
    PLoS One; 2012 Jun 19; 7(8):e43969. PubMed ID: 22952829
    [Abstract] [Full Text] [Related]

  • 14. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R, Rani C, Mahajan P, Vishwakarma RA, Khan IA, Nargotra A.
    ACS Comb Sci; 2016 Feb 08; 18(2):100-16. PubMed ID: 26812086
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
    Li Y, Zhou Y, Ma Y, Li X.
    Carbohydr Res; 2011 Sep 27; 346(13):1714-20. PubMed ID: 21704310
    [Abstract] [Full Text] [Related]

  • 16. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis.
    Mengin-Lecreulx D, van Heijenoort J.
    J Bacteriol; 1994 Sep 27; 176(18):5788-95. PubMed ID: 8083170
    [Abstract] [Full Text] [Related]

  • 17. Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase.
    Zhou Y, Yu W, Zheng Q, Xin Y, Ma Y.
    Glycoconj J; 2012 Aug 27; 29(5-6):297-303. PubMed ID: 22669463
    [Abstract] [Full Text] [Related]

  • 18. Exploring MDR-TB Inhibitory Potential of 4-Aminoquinazolines as Mycobacterium tuberculosis N-Acetylglucosamine-1-Phosphate Uridyltransferase (GlmUMTB ) Inhibitors.
    Patel HM, Palkar M, Karpoormath R.
    Chem Biodivers; 2020 Aug 27; 17(8):e2000237. PubMed ID: 32469443
    [Abstract] [Full Text] [Related]

  • 19. Insights into the central role of N-acetyl-glucosamine-1-phosphate uridyltransferase (GlmU) in peptidoglycan metabolism and its potential as a therapeutic target.
    Soni V, Rosenn EH, Venkataraman R.
    Biochem J; 2023 Jun 18; 480(15):1147-1164. PubMed ID: 37498748
    [Abstract] [Full Text] [Related]

  • 20. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery.
    Sharma R, Khan IA.
    Curr Drug Targets; 2017 Jun 18; 18(14):1587-1597. PubMed ID: 27138757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.